Showing 5,941 - 5,960 results of 16,418 for search '"Therapy"', query time: 0.10s Refine Results
  1. 5941

    Memantine-responsive catatonia secondary to tuberculosis, neurocysticercosis, and pneumococcal pneumonia: A case series by Debanjan Bhattacharjee, Ujjwal Bandyopadhyay

    Published 2023-11-01
    “…Benzodiazepines like lorazepam and electroconvulsive therapy are the conventional treatment modalities for catatonia. …”
    Get full text
    Article
  2. 5942

    Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer by Fadi Nabhan, Elizabeth Kander, Rulong Shen, Amit Agrawal, Vineeth Sukrithan, Ye Zhou, Ashima Goyal, Katie Roll, Manisha Shah, Bhavana Konda

    Published 2021-01-01
    “…Immune check point inhibitor (ICI) therapy can be a potentially effective salvage treatment for anaplastic thyroid cancer (ATC) with progression despite standard of care therapies. …”
    Get full text
    Article
  3. 5943

    Immunological Remission as a Basis for Dose Reduction of Immunosuppressors in Autoimmune Hepatitis: Results of Monocenter Surveillance Study by A. O. Bueverov, S. V. Koblov, P. O. Bogomolov

    Published 2024-03-01
    “…The data of 47 patients with AIH who received immunosuppressive therapy from April 2001 to August 2023 were analyzed: 10 men (21 %), 37 women (79 %); the average age was 37 (17–66) years. …”
    Get full text
    Article
  4. 5944

    The Relevance of Interventional Time and Clinical Outcomes in Patients with NSTEMI Based on the GRACE Score by Ji-Xiang Wang, Jing Gao, Jian-Yong Xiao, Ming-Dong Gao, Nan Zhang, Peng-Ju Lu, Yin Liu

    Published 2022-01-01
    “…Patients were grouped according to the GRACE score and the time from admission to intervention therapy. The Cox multivariate risk regression model was used to analyze the correlation between the GRACE score and the time from admission to intervention therapy with major adverse cardiovascular events (MACEs). …”
    Get full text
    Article
  5. 5945
  6. 5946

    PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma by San-Chi Chen, Hsiang-Ling Ho, Chien-An Liu, Yi‑Ping Hung, Nai-Jung Chiang, Ming‑Huang Chen, Yee Chao, Muh-Hwa Yang

    Published 2025-02-01
    “…Prothrombin induced by vitamin K absence II (PIVKA-II) is more sensitive for HCC detection, though its role in systemic therapy remains underexplored. This study aimed to evaluate PIVKA-II in non-AFP-secreting HCC treated with systemic therapy. …”
    Get full text
    Article
  7. 5947
  8. 5948

    Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment by Liubov A. Tashireva, Irina V. Larionova, Irina V. Larionova, Nikita A. Ermak, Anastasia A. Maltseva, Ekaterina I. Livanos, Anna Yu. Kalinchuk, Marina N. Stakheyeva, Larisa A. Kolomiets

    Published 2025-01-01
    “…Our review summarizes accumulated data on the role of cells of the tumor microenvironment and their regulatory molecules in the mechanisms underlying therapeutic effects of immune checkpoint inhibitors, including resistance to therapy. Major question we raise here – which group of patients is the most favorable to achieve durable immunotherapy response in endometrial cancer?…”
    Get full text
    Article
  9. 5949

    Harnessing nanotechnology for cancer treatment by Jiajun Zhu, Jiajun Zhu, HaeJu Lee, HaeJu Lee, Ruotong Huang, Ruotong Huang, Jianming Zhou, Jingjun Zhang, Xiaoyi Yang, Wenhan Zhou, Wangqing Jiang, Shuying Chen

    Published 2025-01-01
    “…Nanotechnology has become a groundbreaking innovation force in cancer therapy, offering innovative solutions to the limitations of conventional treatments such as chemotherapy and radiation. …”
    Get full text
    Article
  10. 5950

    A Network Investigation on Idiopathic Hypogonadotropic Hypogonadism in China by Weiwei Zhao, Hongying Ye, Xiaolong Zhao, Zhaoyun Zhang, Shouyue Sun, Yiran Jiang, Min He, Cheng Xu, Renming Hu, Yiming Li

    Published 2013-01-01
    “…The results of our cross-sectional study showed the effectiveness of hormone replacement therapy for IHH and implied that gonadotropin and androgen replacement therapy may be superior to gonadotropin treatment alone.…”
    Get full text
    Article
  11. 5951

    Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α by Kaimin Song, Huitong Wang, Dawu Zeng, Yunyun Qian, Zhixiang Guo, Huatang Zhang, Yijuan Zheng, Yongjun Zhou, Xueping Yu, Zhijun Su

    Published 2025-02-01
    “…Background: As an uncommon serological pattern, the effect of hepatitis B e antigen/anti-hepatitis B e (HBeAg/anti-HBe) coexistence on peginterferon-α (Peg-IFN-α) therapy in patients with chronic hepatitis B (CHB) remains unknown. …”
    Get full text
    Article
  12. 5952

    Efficacy of Kolofort in Combined Functional Gastroenterological Pathology: an Open Study by Yu. P. Uspenskiy, O. S. Mirzoev, Yu. A. Fominykh, A. A. Gnutov, S. V. Polyushkin

    Published 2020-12-01
    “…All patients received Kolofort 2 times a day, 2 tablets per dose for 28 days.Results. The Kolofort therapy improved the clinical symptoms according to the “7x7” questionnaire; the primary mean total score was 17.7 ± 3.6, decreased to 10.3 ± 2.5 past 14 days (p < 0.0001) and to 7.6 ± 1.5 - past 28 days of therapy (p < 0.0001). …”
    Get full text
    Article
  13. 5953

    Disparities in Opioid Use Disorder Treatment Admissions in the United States by Peter J. Mallow, Michael Mercado, Michael Topmiller

    Published 2020-06-01
    “…The fully saturated regression results found that the odds of Cincinnati individuals receiving planned medication-assisted therapy were 0.497 (95% CI, 0.451–0.546; P value < 0.001). …”
    Get full text
    Article
  14. 5954

    Protocol for evaluating the effects of integrating music with taekwondo training in children with autism spectrum disorder: A randomized controlled trial. by Clare C W Yu, Kam M Mok, Emma Mak, Chun T Au, Dorothy F Y Chan, Stanley Wu, Raymond C K Chung, Matthew C K Ip, Simpson W L Wong

    Published 2025-01-01
    “…In the "Taekwondo training with elements of music therapy" group, elements of music therapy will be incorporated into the Taekwondo training. …”
    Get full text
    Article
  15. 5955

    Platelet Rich Plasma in the Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw: Personal Experience and Review of the Literature by F. Longo, A. Guida, C. Aversa, E. Pavone, G. Di Costanzo, L. Ramaglia, F. Ionna

    Published 2014-01-01
    “…In our study, we considered 72 patients with BRONJ with nonsurgical therapy, surgical therapy, and surgical therapy with platelet rich plasma (PRP) gel to evaluate its therapeutic effect in promoting ONJ wounds healing. …”
    Get full text
    Article
  16. 5956

    First-line glaucoma monotherapy medication patterns in Finland during 1995-2019 based on a population-based study. by Petri K M Purola, Seppo V P Koskinen, Hannu M T Uusitalo

    Published 2025-01-01
    “…Timolol fixed-combinations were the most common second-line glaucoma therapy with a share of 39% after 5 years of follow-up.…”
    Get full text
    Article
  17. 5957

    Mortality Related Risk Factors in High-Risk Pulmonary Embolism in the ICU by Begüm Ergan, Recai Ergün, Taner Çalışkan, Kutlay Aydın, Murat Emre Tokur, Yusuf Savran, Uğur Koca, Bilgin Cömert, Necati Gökmen

    Published 2016-01-01
    “…The treatment of choice for group 1 was thrombolytic therapy in 29 (70.7%) and anticoagulation in 12 (29.3%) patients. …”
    Get full text
    Article
  18. 5958

    Clinical Characteristics and Risk Factors for Multidrug-Resistant Enterobacter cloacae Complex Bacteremia in a Chinese Tertiary Hospital: A Decade Review (2013&ndash;2022) by Han M, Hua M, Xie H, Li J, Wang Y, Shen H, Cao X

    Published 2025-01-01
    “…MDR ECC accounted for 30.9% (58/188). Previous antibiotic therapy was an independent risk factor for MDR ECC (OR = 3.193, P < 0.020), while appropriate antibiotic therapy significantly reduced the risk (OR = 0.279, P < 0.001). …”
    Get full text
    Article
  19. 5959

    Surgical Treatment Patterns, Healthcare Resource Utilization, and Economic Burden in Patients with Tenosynovial Giant Cell Tumor Who Underwent Joint Surgery in the United States by Feng Lin, Winghan J. Kwong, Sherry Shi, Irina Pivneva, Eric Q. Wu, John A. Abraham

    Published 2022-03-01
    “…Opioids and nonsteroidal anti-inflammatory drugs (NSAIDs), and physical therapy, occupational therapy, and rehabilitation services, were commonly used during baseline (45%, 40%, and 30%, respectively). …”
    Get full text
    Article
  20. 5960

    Analgesia Evaluation of 2 NSAID Drugs as Adjuvant in Management of Chronic Temporomandibular Disorders by Fernando Kurita Varoli, Murillo Sucena Pita, Sandra Sato, João Paulo Mardegan Issa, Cássio do Nascimento, Vinícius Pedrazzi

    Published 2015-01-01
    “…Statistical analysis has shown that, after 10 days of treatment, all therapies were effective for pain relief. NSAID therapy promoted analgesia on the third day, while placebo only promoted analgesia in the eighth day. …”
    Get full text
    Article